Published in Transplant Proc on December 01, 1996
Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest (1998) 1.30
Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis. Ann Surg (2000) 0.77
Chronic allograft rejection. Immunol Rev (1993) 1.18
Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J (1995) 0.93
Pathophysiology of allograft arteriosclerosis. Transplant Proc (1993) 0.80
Molecular pathology of acute and chronic rejection. Transplant Proc (1994) 0.78
Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis. Transplant Proc (1991) 0.78
Chronic allograft rejection: an update. Clin Transplant (1994) 0.78
Role of growth factors in graft vessel disease. Transplant Proc (1995) 0.78
Immunobiology and pathology of chronic rejection. Transplant Proc (1997) 0.77
Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J (1993) 0.77
Pathology makes the difference. Transplantation (2000) 0.75
Chronic rejection: new potential venues of therapy. Transplant Proc (1999) 0.75
Pathophysiology and diagnosis of acute rejection. Transplant Proc (1999) 0.75
Blockade of growth factor synthesis and growth factor action: two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury. Metabolism (1996) 0.75
Donor-directed cytotoxic T cells and other inflammatory components of acute allograft rejection. Ann N Y Acad Sci (1988) 0.75
Clinical and experimental chronic allograft rejection. Transplant Proc (1994) 0.75
Discontinuation of one drug in triple-drug immunosuppression with cyclosporine, azathioprine, and steroids: an interim report. Transplant Proc (1988) 0.75
Diagnosis of rejection: role of fine-needle aspiration biopsy. Transplant Proc (1990) 0.75
Chronic allograft rejection. Transplant Proc (1996) 0.75
CMV infection and allograft rejection. Transplant Proc (1998) 0.75
Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection. Transplant Proc (1993) 0.75
Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection. Transplant Proc (1987) 0.75
Chronic rejection: risk factors, regulation, and possible sites of therapeutic intervention. Transplant Proc (1998) 0.75
Cellular and molecular biology of chronic rejection. Transplant Proc (1995) 0.75
Common pathways in allograft arteriosclerosis and experimental vascular injury: new potential sites of inhibition. Transplant Proc (1998) 0.75
Cellular and molecular mechanisms in allograft arteriosclerosis. Transplant Proc (1992) 0.75
Transplant aspiration cytology: applications to kidney and liver transplantations. Transplant Proc (1991) 0.75